The study is designed to compare the abuse liabilities of intravenous buprenorphine and
buprenorphine/naloxone in individuals who are physically dependent on sublingual
buprenorphine. We hypothesize that the abuse liability of buprenorphine/naloxone is lower
than that of buprenorphine alone.
Phase:
Phase 3
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
Schering-Plough
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Heroin Naloxone